Advertisement
Advertisement
U.S. markets open in 5 hours 35 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NEXGEL, Inc. (NXGL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.1700-0.0400 (-3.31%)
At close: 03:54PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close1.2100
Open1.2200
Bid0.0000 x 1100
Ask0.0000 x 1800
Day's Range1.1500 - 1.2200
52 Week Range1.1400 - 4.6600
Volume17,367
Avg. Volume17,948
Market Cap6.52M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NXGL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NexGel, Inc
    Daily – Vickers Top Buyers & Sellers for 01/04/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more
  • Benzinga

    NexGel Highlights Positive Data From Proof-of-Concept Study For Its Diclofenac Hydrogel Pain Treatment

    NexGel Inc (NASDAQ: NXGL) announced results from its proof-of-concept study for its diclofenac hydrogel patches. The patches are designed to treat pain indications such as arthritis, joint pain, muscle aches, and more. The study compared NexGel's diclofenac hydrogel patches with the leading commercially available topical treatment. It assessed the formulations, skin retention, and permeation of the products through the skin. The results revealed that NexGel's diclofenac hydrogel patches delivere

Advertisement
Advertisement